Aglaris
PrivateLast Round
Grant
Apr 1, 2019
Total Funding Raised
$1.67M
Company Overview
Aglaris is a biotechnology company that develops and manufactures fully automated, closed-system bioreactors for cell and gene therapy production.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aglaris Comparables
Compare Aglaris with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Scinus Cell Expansion | 91% | |
| Limula | 89% | |
| MFX | 87% | |
Aglaris Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 1, 2019 | ||||
| Grant | Jun 1, 2016 | ||||
| VC Round | Mar 1, 2016 |
Key People
Founding team and executive leadership
Aglaris Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Commission | Grant |
| CRB Bio II | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 2, 2025
Grew 36% QoQ, from 11 to 15 employees.
- Apr 5, 2025
Grew 27% QoQ from 11 to 14 employees.
Aglaris Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Aglaris's valuation, stock price, and market status.